Clinical Trial Search

Primary: Average Change in Hot Flash Activity Score From Baseline to Week 7 for Low Dose Oxybutynin vs Placebo and for High Dose Oxybutynin vs Placebo — -16.9; -10.6; -5.7 score…

Primary: Global Ventilated Lung Volume — 61.73; 56.73 Percentage of total lung volume — p=0.0254

Primary: Number of Participants With Shigellosis — 0; 2; 1; 4 Participants

Primary: Number of Participants With Clinically Significant Effects (Adverse Events) — 0; 0; 0; 0 Participants

Primary: Unused Opioids — 5; 10 oxycodone 5mg tablets

Primary: Change From the Baseline Value in HbA1c at Month 3 and 6 — 0.2; -0.6; 0; -0.6 Percent Change — p=<0.001

Primary: Change From the Baseline Value in HbA1c at Month 3 and 6 — 0.2; -0.6; 0; -0.6 Percent Change — p=<0.001

Primary: Postoperative Pain Scores — 4.76; 7.38; 3.7; 6.66 units on a scale

Primary: Number of Patients With a Composite Outcome : Bladder Wound, Rectum Wound, Abnormal Bleeding — 6 Participants

Primary: Area Under the Concentration-Time Curve From Zero to 24 Hours After Dosing (AUC0-24) of R-Methadone — 55.8; 53.2 ng*hr/mL/mg

Primary: Number of Participants With One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration — 0; 0; 0; 0 Participants

Primary: Humoral Immune Response for A/Indonesia/05/2005 (H5N1) Strain in Terms of Vaccine-homologous Haemagglutination Inhibition (HI) Antibody Titers Following Primary…

Primary: Sleep Quality — 6.25; 9.87 score on a scale — p=<.001

Primary: Self-Care Activities: Healthy Eating — 4.23; 4.67; 4.61; 4.60 days/week (min: 0 days; Max: 7 days)

Primary: Percentage of Adherent Participants — 65; 38 percentage of participants — p==0.004